Tecogen Inc.
TGEN
$0.74
$0.0253.50%
| Weiss Ratings | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D- | |||
| Reward Grade | E | |||
| Rating Factors | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Good | |||
| Total Return Index | Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.05 | |||
| Price History | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | -3.52% | |||
| 30-Day Total Return | -8.53% | |||
| 60-Day Total Return | -1.33% | |||
| 90-Day Total Return | -6.33% | |||
| Year to Date Total Return | -5.13% | |||
| 1-Year Total Return | -30.84% | |||
| 2-Year Total Return | -44.36% | |||
| 3-Year Total Return | -59.34% | |||
| 5-Year Total Return | -78.30% | |||
| 52-Week High % Change | -42.64% | |||
| 52-Week Low % Change | 26.50% | |||
| Price | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $1.29 | |||
| 52-Week Low Price | $0.59 | |||
| 52-Week Low Price (Date) | Apr 22, 2024 | |||
| 52-Week High Price (Date) | Jul 20, 2023 | |||
| Valuation | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 18.39M | |||
| Enterprise Value | 19.40M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.18 | |||
| Earnings Per Share Growth | 6.74% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | 0.71 | |||
| Price/Book (Q) | 1.34 | |||
| Enterprise Value/Revenue (TTM) | 0.75 | |||
| Price | $0.74 | |||
| Enterprise Value/EBITDA (TTM) | -5.61 | |||
| Enterprise Value/EBIT | -4.78 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 24.85M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 781 466 6400 | |||
| Address | 45 First Avenue Waltham, MA 02451 | |||
| Website | www.tecogen.com | |||
| Country | United States | |||
| Year Founded | 2000 | |||
| Profitability | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -15.63% | |||
| Profit Margin | -16.23% | |||
| Management Effectiveness | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -8.94% | |||
| Return on Equity | -- | |||
| Income Statement | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | 25.95M | |||
| Total Revenue (TTM) | 25.95M | |||
| Revenue Per Share | $1.04 | |||
| Gross Profit (TTM) | 10.69M | |||
| EBITDA (TTM) | -3.46M | |||
| EBIT (TTM) | -4.06M | |||
| Net Income (TTM) | -4.21M | |||
| Net Income Avl. to Common (TTM) | -4.21M | |||
| Total Revenue Growth (Q YOY) | 14.99% | |||
| Earnings Growth (Q YOY) | 26.11% | |||
| EPS Diluted (TTM) | -0.18 | |||
| EPS Diluted Growth (Q YOY) | 25.83% | |||
| Balance Sheet | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | 1.51M | |||
| Cash Per Share (Q) | $0.06 | |||
| Total Current Assets (Q) | 19.73M | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | 13.61M | |||
| Current Ratio (Q) | 1.757 | |||
| Book Value Per Share (Q) | $0.55 | |||
| Total Assets (Q) | 28.46M | |||
| Total Current Liabilities (Q) | 11.23M | |||
| Total Debt (Q) | 2.71M | |||
| Total Liabilities (Q) | 14.85M | |||
| Total Common Equity (Q) | 13.69M | |||
| Cash Flow | TGEN - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -254.00K | |||
| Cash from Financing (TTM) | 425.70K | |||
| Net Change in Cash (TTM) | -118.60K | |||
| Levered Free Cash Flow (TTM) | 2.12M | |||
| Cash from Operations (TTM) | -290.30K | |||
